4.7 Article

Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility

Journal

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 50, Issue 8, Pages 2892-2894

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00349-06

Keywords

-

Funding

  1. NIAID NIH HHS [R01 AI047718, AI054289, R03 AI054289, AI47718] Funding Source: Medline

Ask authors/readers for more resources

A recognized hotspot for mutations conferring reduced echinocandin susceptibility (RES) is residue S645 of Candida albicans Gsc1(Fks1). We report that the mutation F641Y is associated with RES in a C albicans isolate. The analogous Fks2 residue is mutated F to V in a Candida glabrata RES isolate; the introduction of this mutation into susceptible C glabrata confirmed its role in RES. Y641-equivalent Fks residues were identified in intrinsically RES Fusarium species and Candida guilliermondii.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available